Slideshow
Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.
Multimorbidity Screening Reduced Hospitalizations in Patients With Rheumatic Diseases
Emerging Agents in the Treatment of Rheumatic Diseases
Methotrexate May Lower Vaccine Response in Patients With RA
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
EP-104IAR Phase 2 Data Shows Potential for Knee Osteoarthritis Pain
Study Identifies Gut Microbiome Makeup, Diversity Differences in People With Fibromyalgia